The Chinese ST-Segment Elevation Myocardial Infarction Primary Percutaneous Coronary Intervention Registry
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 5,594
- 试验地点
- 1
- 主要终点
- death
研究概览
简要总结
The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.
详细描述
The CSPR trial is an observational clinical trial to derive and validate a readily useable risk score to identify patients at high risk of in-hospital major adverse cardiac events in 5594 patients presenting with a ST-segment elevation myocardial infarction and treated by primary percutaneous coronary intervention.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •ST-segment elevation myocardial infarction was defined according to the universal definition of myocardial infarction
- •STEMI treated by pPCI
排除标准
- •Patient with heart failure in admission
- •STEMI with symptom-onset-to-balloon time>24h
- •pPCI was not successful or only underwent coronary angiography
- •Killip class ≥II in admission
结局指标
主要结局
death
时间窗: in-hospital outcome, until discharge
according to the universal definition
in-hospital acute de novo heart failure
时间窗: in-hospital outcome, until discharge
Killip class ≥II
cardiogenic shock
时间窗: in-hospital outcome, until discharge
according to the universal definition
次要结局
未报告次要终点